Impact of pretreatment body mass index on the survival of head and neck cancer patients.
Zheng YangJobran MansourPeng SunPeng WeiKristina R DahlstromMark ZafereoGuojun LiNeil D GrossPublished in: Head & neck (2024)
This exploratory analysis suggests that pretreatment BMI could be an independent prognostic factor of survival outcomes in SCCHN patients, particularly in patients with HPV-positive oropharyngeal cancer tumors. Further prospective investigations are warranted.